"Pfizer and BioNTech Granted FDA Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Ages 12 Years and Older" https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-granted-fda-emergency-use-authorization
EMA CHMP har møde i morgen om Omikron BA.1 vacciner fra Moderna og fra Pfizer/Biontech. "The aim of the meeting is to conclude the evaluation of the two applications, if possible."
https://www.ema.europa.eu/en/events/extraordinary-meeting-committee-medicinal-products-human-use-chmp-1-september-2022
https://www.ema.europa.eu/en/events/extraordinary-meeting-committee-medicinal-products-human-use-chmp-1-september-2022
1/9 2022 14:35 Occam 0105820
First adapted COVID-19 booster vaccines recommended for approval in the EU.
https://www.ema.europa.eu/en/news/first-adapted-covid-19-booster-vaccines-recommended-approval-eu
https://www.ema.europa.eu/en/news/first-adapted-covid-19-booster-vaccines-recommended-approval-eu